| 08.26 (Tuesday) |
| Conference Room 307 (3F) |
307A |
10:00 - 12:30 |
AI@BIO: Acceleration of Innovation |
Korea Institute of Toxicology (KIT) |
K |
| 10:00 - 10:20 |
Excavation/ Derivation Discovery and derivation of candidate substances such as new drugs using AI technology |
CALICI |
Youngbin Park, Director |
| 10:20 - 10:40 |
Diagnosis/Prediction Evolution of efficacy/toxicity prediction, diagnostic and analytical technologies Aigendrug |
Aigendrug |
Sun Kim, CEO |
| 10:40 - 11:00 |
Platform New indications for drugs discovered by AI |
Oncocross |
Yirang Kim, CEO |
| 11:00 - 11:20 |
Digital Twin Big data based virtual clinical trial progress |
BASGENBIO |
Ho Kim, CEO |
| 11:20 - 11:40 |
Manufacturing Innovation Innovation Cases in Bio Production Processes Driven by AI Agents and LLMs |
Cellkey AI |
Wayne Lee, CEO |
| 11:40 - 12:30 |
<Networking:
Conference on Global Trends and Approval Strategies for Functional Ingredients> |
| 307B |
13:30 - 16:45 |
Conference on Supporting the Export and Approval Strategies for Functional Ingredients
* The number of participants per company for this session is limited to 2. |
Ministry of Food and Drug Safety (KFDA) |
K |
| 13:35 - 13:55 |
Food Supplement Regulatory Systems Abroad |
Seoul National University of Science and Technology |
Jiyeon Kim, Professor |
| 13:55 - 14:15 |
Current trends of global regulatory research on functional food ingredients |
Korea University, Food Regulatory Science |
Youngjun Kim, Professor |
| 14:15 - 14:35 |
Global expansion strategy for Lactobacillus gasseri BNR17 |
AceBiome Inc. |
Changhoon Kang, Strategy & Development Team |
| 14:35 - 14:55 |
Outcomes of technical supports fo Health Functional Ingredient |
International Life Science Institute Korea |
Eunju Kim, Executive Director |
| 15:25 - 15:45 |
Policy in Health Functional Foods |
Ministry of Food and Drug Safety (KFDA) |
Eunju Choi, Deputy Director |
| 15:45 - 16:05 |
Health Functional Food Standards and Specifications |
Ministry of Food and Drug Safety (KFDA) |
Namkyu Sun, Deputy Director |
| 16:05 - 16:25 |
Recognition of Functional Ingredients and Evaluation Guidelines |
Ministry of Food and Drug Safety (KFDA) |
Yongmu Kim, Deputy Director |
| 16:25 - 16:45 |
Cases of requests for additional information and Improved precedure system in Food functional Ingredients approval |
Ministry of Food and Drug Safety (KFDA) |
Eunchae Seo, Scientific Officer |
| Conference Roon 308 (3F) |
308A |
13:00 - 15:10 |
The King of Ayurveda ; KSM-66 Ashwagandha with the proven science and how people would benefit from |
Kolmar BNH |
Sung Jin Lee, General Manager |
K |
| 308B |
13:00 - 15:10 |
Collaborative Technology Commercialization TF (CITC) Promising Technology Briefing (Health Functional Foods Division)
* The number of participants per company for this session is limited to 4. |
National Research Council of Science & Technology (NST) & Collaborative Technology Commercialization TF (CITC) & Korea Health Functional Food Association (KHFF) |
K |
| 13:00 - 13:10 |
Greetings |
| 13:10 - 13:40 |
Development of Immune Enhancing Functional Materials using Natural Products and Probiotics |
Korea Food Research Institute (KFRI) |
Hee Soon Shin, Principal Researcher
So-Young Lee, Principal Researcher |
| 13:40 - 14:10 |
Development of prebiotics to improve gut health for body fat reduction |
Korea Food Research Institute (KFRI) |
Ho-Young Park, Principal Researcher |
| 14:10 - 14:40 |
Development of a Natural Muscle Strengthening Agent Based on Centaurea cyanus Extract |
Korea Institute of Science and Technology(KIST) |
Myung-suk Kim, Principal Researcher |
| 14:40 - 15:10 |
Functional Natural Material for Hair Growth |
Korea Research Institute of Bioscience and Biotechnology(KRIBB) |
Mun-ock Kim, Principal Researcher |
| 15:10 - 16:00 |
Closing |
| 14:40 - 17:05 |
<Collaborative Technology Commercialization TF (CITC) Promising Technology Partnering Session>
* Location: Conference Room 303, 304
* This program is exclusively open to members of KHFF. |
| 08.27 (Wednesday) |
| Conference Room 307 (3F) |
307C |
10:00 - 12:30 |
DIPS‘OPEN’TOX SCHOOL |
Korea Institute of Toxicology (KIT) |
K |
| 10:00 - 11:40 |
Open Lecture Successful Nonclinical Study and IND Strategy: Toxicology Testing and MRSD Gap Analysis |
AI TOX |
Youngchul Park, CEO |
E |
| 11:40 - 12:00 |
Special Lecture SFDA regulations in Saudi Arabia and regional drug registration frameworks |
Creativity Ocean |
Mr. Abdullah Al Mohizea, Chairman of Creativity Ocean |
K |
| 12:00 - 12:30 |
<Consulting>
* Pre-matching/ Location will to be confirmed |
|
| 307D |
13:30 - 17:00 |
2025 Health Functional Foods Export Strategy Seminar
* This session is exclusively open to members of KHFF.
* The number of participants per company for this session is limited to 4. |
Korea Agency of HACCP Accreditation and Services (KAHAS) & Korea Health Functional Food Association (KHFF) |
|
| 13:30 - 14:50 |
Part 1 Expansion into Major Countries via Online Platforms |
K |
| 13:30 - 14:10 |
Entering Japan’s Health Supplement Market via Amazon Japan, Japan’s Largest E-Commerce Channel |
Amazon Korea |
Kyuho Kim Manager |
K |
| 14:10 - 14:50 |
Tmall Cross-border E-commerce Analysis & Tmall Global Onboarding Guide |
Tmall Global |
Paul Kim Manager |
K |
| 15:00 - 16:50 |
Part 2 Market Overview and Entry Strategies for Health Functional Foods in Major Countries |
|
| 15:00 - 15:30 |
Strategies and Trends for Entering the U.S. Health Functional Foods Market |
GABSAN |
Youngseok Kim, CEO |
K |
| 15:30 - 16:10 |
Understanding the Vietnamese Health Supplement Market and Export Strategies Market and Export Strategies |
Hoan TT company Import - Export Investment company Limited |
Nguyen Quynh Mai, Marketing Director |
E |
| 16:10 - 16:50 |
Understanding Key Distribution Channels and Consumer Trends in the Thailand Market |
Vicchi Enterprise Co.,Ltd |
Mr.Nuttanun Leamkrajang, Sale and Marketing / Assistant Petfood Division Manager |
E |
|
|
|
<1:1 Business Meetings with International Buyers>
* Pre-matching
* Date and Time: 08.26 (Tuesday) 10:00 - 17:00
* Location: Conference Rooms 312, 313, 316, 319, 323, 326 |
K |
| Conference Room 308 (3F) |
308C |
10:20 - 17:00 |
2025 Biohealth Policy Forum: KDRA InnoPol – Biohealth Innovation Consortium on AI and Big Data Utilization |
Korea Drug Research Association (KDRA) |
K |
| 10:20 - 10:50 |
Launch of the Biohealth Innovation Council for AI and Big Data |
Korea Drug Research Association (KDRA) |
Jeongjin Kim, Chairman |
| 10:50 - 11:00 |
Greetings |
InnoPol |
Younghyun Choi, President |
| 11:00 - 11:30 |
Global Trends in New Drug Development Using AI and Big Data |
GlobalData |
Hyojin Park, Director |
| 11:30 - 12:00 |
Data Collection and Utilization Using On-Device AI |
Personal AI |
Jaeyoung Lee, CEO |
| 308D |
13:30 - 13:55 |
Innovation in Drug Development Through a Protein Structure-Based AI Platform – The Pharmaco-Net Case Study |
CALICI |
Youngbin Park, CSO |
| 13:55 - 14:20 |
Applications of AI in Drug Development – Preclinical and Clinical Case Studies |
Pharos iBio |
Jinsun Kwon, Director |
| 14:20 - 14:45 |
Strategic Utilization and Monetization of Medical Data |
Predictive AI |
Sajung Yun, CEO |
| 14:45 - 15:10 |
Case Studies on Data-Driven Smart Manufacturing Applications |
MakinaRocks |
Hanseung Koh, Business Development Senior Executive |
| 15:10 - 15:35 |
Strategies to Enhance the Effectiveness of Bio-Innovation Leveraging Digital Technologies for New Drug Development |
Korea Research Institute of Bioscience and Biotechnology (KRIBB) |
Heoungyeol Kim, Director |
| 15:35 - 16:00 |
Government's Digital Bio Innovation Strategy |
Ministry of Science and ICT (MSIT) |
|
| 16:00 - 16:10 |
Break |
| 16:10 - 17:00 |
<Panel Discussion Global Growth Strategies Across the Bio-Health Value Chain Based on AI and Big Data> |
Panel Moderator: Younghyun Choi (InnoPol)
Panels: Hyojin Park (GlobalData), Jaeyoung Lee (Personal AI), Jaemoon Choi (CALICI), Jinsun Kwon (Pharos iBio), Hanseung Koh (MakinaRocks), Yongseok Hong (Korea Medical Data Association), Yuntaek Jung (Pharmaceutical Strategy Institute), Heonje Cho (KDRA) |
| 08.28 (Thursday) |
| Conference Room 307 (3F) |
307E |
10:20 - 11:00 |
Todays CEP
| MARA Consultancy |
Marieke van Dalen, Global Regulatory Specialist |
E |
| 11:00 - 11:20 |
Break |
| 11:20 - 12:00 |
A gap analysis between regulatory requirements on a global scale |
| 307F |
13:30 - 16:20 |
Health Functional Food Distribution Trends Seminar
* This session is exclusively open to members of KHFF.
* The number of participants per company for this session is limited to 4. |
Korea Health Functional Food Association (KHFF) |
K |
| 13:30 - 14:20 |
2025 First Half Online Shopping Industry Review and Future Outlook |
Seoul National University |
Miah Lee, Researcher of Research Institute of Human Ecology |
| 14:30 - 15:00 |
Health Functional Food Growth During an Economic Downturn: Consumer Trends in Korea Across On/Offline Retail Channels |
NIQ KOREA |
Taehyun Kim, Senior Manager |
| 15:10 - 15:40 |
Health Functional Food Category and Customer Trends in Coupang |
Coupang |
Kyuchoel Shim (James), Sr. Manager |
| 15:50 - 16:20 |
CJ OnStyle Paradigm Shift: Successful Strategies for Mobile Live Commerce |
CJ ENM |
Donghoon Sung, Executive Director (Head of E-Commerce Division) |
10:20 - 12:20
13:00 - 15:00 |
<Business Meeting with Distribution MDs for Health Functional Foods>
* Location: Matchmaking Room(#L34) at Hall A, Matchmaking Room(#PA18) at The Platz Hall
* This program is exclusively open to members of KHFF. |
| Conference Room 308 (3F) |
| 308E |
10:20 - 15:30 |
2nd Annual Seminar of the KDRA Microneedle Convergence Research Society 2025 |
Korea Drug Research Association (KDRA) |
K |
| 10:30 - 12:00 |
Part 1 Panel Moderator: Shayan F. Lahiji, CTO of CURSUS BIO |
| 10:30 - 11:00 |
Current Status of Overseas Regulations and the Need for Standardization of Microneedle Formulations |
Korea Drug Research Association (KDRA) |
Heonje Cho, Managing Director |
| 11:00 - 11:30 |
Nonclinical Study Strategies and Considerations for Microneedle Formulations |
HLB bioCode |
Taewon Jeon, Executive Director |
| 11:30 - 12:00 |
Development and IND Approval Strategy for Microneedle Formulations |
MEDITIP |
Yangsoo Park, CEO |
| 308F |
13:30 - 15:30 |
Part 2 Panel Moderator: Kyungwon Seo, Vice President of Continuing Education Center for Advanced Pharmacy, Seoul National University |
| 13:30 - 14:00 |
Microneedle-Based Tumor Microenvironment Modulation Technology |
CURSUS BIO |
Jaehyun Kim, Senior Researcher |
| 14:00 - 14:30 |
Development and Challenges of Microneedle Patch-Type BCG Vaccine |
Snvia |
Semin Kim, Executive Director |
| 14:30 - 15:00 |
FDA OTC Approval Strategy for Microneedle Formulations |
SmallLab |
Jinwook Lee, Director |
| 15:00 - 15:30 |
Quality Considerations for Microneedle Pharmaceuticals |
National Institute of Food and Drug Safety Evaluation (NIFDS) |
Jungyoon Choi, Senior Research Officer |
